Supplements

Blue light therapy delivered through LED-integrated glasses improves sleep quality and reduces daytime sleepiness in Parkinson's disease

In a randomized, placebo-controlled pilot study, Parkinson's disease patients using blue light glasses for 2 weeks showed significantly better Pittsburgh Sleep Quality Index scores compared to red light placebo at 5 weeks (p=0.029, effect size=0.896). Clinically significant daytime sleepiness dropped from 50% to 6.7% in the blue light group.

Last updated: Aug 11, 2026•1 RCTs•📖 Read as article →

Evidence Score

Evidence Score44/100
Human RCT★★☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Blue light therapy delivered through light glasses improves sleep quality and daytime sleepiness in Parkinson's disease: A randomized trial.

rct

Śmiłowska K, de Vries NM, Bloem BR, van Wamelen DJ · Journal of Parkinson's disease (2026)

Participants: 30
Duration: 5 weeks (2-week intervention, 3-week follow-up)
Intervention: Blue light therapy via LED-integrated glasses, 1 hour twice daily for 2 weeks
Outcome: Sleep quality (Pittsburgh Sleep Quality Index), daytime sleepiness, mood, anxiety, motor symptoms
Effect Size: 0.896 (large effect size for sleep quality at 5 weeks)
Population: Adults with Parkinson's disease and sleep disturbances (n=30 total, 15 per group)

Result: In a randomized, placebo-controlled pilot study, Parkinson's disease patients using blue light glasses for 2 weeks showed significantly better Pittsburgh Sleep Quality Index scores compared to red light placebo at 5 weeks (p=0.029, effect size=0.896). Clinically significant daytime sleepiness dropped from 50% to 6.7% in the blue light group.

PubMed: 42558005DOI: 10.1177/1877718X261468544

Mechanism Graph

Blue light exposure stimulates melanopsin-containing retinal ganglion cells
↓
This signals the suprachiasmatic nucleus to shift circadian phase
↓
Improved circadian alignment enhances nocturnal sleep consolidation
↓
Result: Better sleep quality and reduced daytime sleepiness

Limitations

  • ⚠Small pilot study with only 30 participants
  • ⚠Single-blind design (participants may have guessed group assignment due to visible light color)
  • ⚠Short intervention and follow-up period (5 weeks total)
  • ⚠No objective sleep measures (e.g., polysomnography or actigraphy)

Frequently Asked Questions

How does blue light glasses therapy compare to traditional light boxes?▼

Blue light glasses deliver lower light intensities and are wearable, eliminating the need to sit in front of a light box, making it more convenient for daily use.

How long do the benefits last after stopping blue light therapy?▼

In this study, sleep quality improvements were still present at 5 weeks, which was 3 weeks after the 2-week intervention ended.

Is blue light therapy safe for Parkinson's patients?▼

The study did not report adverse events, but as a pilot, more research is needed to confirm safety and optimal dosing.

What was the placebo in this study?▼

Red light glasses were used as a placebo, as red light does not have the same circadian effects as blue light.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Śmiłowska K, de Vries NM, Bloem BR, van Wamelen DJ. "Blue light therapy delivered through light glasses improves sleep quality and daytime sleepiness in Parkinson's disease: A randomized trial.." Journal of Parkinson's disease, 2026. PMID: 42558005 DOI: 10.1177/1877718X261468544
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.